{
    "Rank": 216,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT00900523",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "VICC GYN 0648"
                },
                "SecondaryIdInfoList": {
                    "SecondaryIdInfo": [
                        {
                            "SecondaryId": "VU-VICC-GYN-0648"
                        },
                        {
                            "SecondaryId": "VU-VICC-IRB-060680"
                        }
                    ]
                },
                "Organization": {
                    "OrgFullName": "Vanderbilt-Ingram Cancer Center",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer",
                "OfficialTitle": "Urine Prostaglandin-M(PGE-M) in Ovarian Cancer"
            },
            "StatusModule": {
                "StatusVerifiedDate": "April 2013",
                "OverallStatus": "Completed",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "November 2006"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "July 2007",
                    "PrimaryCompletionDateType": "Actual"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "July 2008",
                    "CompletionDateType": "Actual"
                },
                "StudyFirstSubmitDate": "May 9, 2009",
                "StudyFirstSubmitQCDate": "May 9, 2009",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "May 12, 2009",
                    "StudyFirstPostDateType": "Estimate"
                },
                "LastUpdateSubmitDate": "April 17, 2013",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "April 18, 2013",
                    "LastUpdatePostDateType": "Estimate"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Principal Investigator",
                    "ResponsiblePartyInvestigatorFullName": "Marta Crispens, MD",
                    "ResponsiblePartyInvestigatorTitle": "Associate Professor; Gynecological Oncologist",
                    "ResponsiblePartyInvestigatorAffiliation": "Vanderbilt-Ingram Cancer Center"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Vanderbilt-Ingram Cancer Center",
                    "LeadSponsorClass": "OTHER"
                },
                "CollaboratorList": {
                    "Collaborator": [
                        {
                            "CollaboratorName": "National Cancer Institute (NCI)",
                            "CollaboratorClass": "NIH"
                        }
                    ]
                }
            },
            "OversightModule": {
                "OversightHasDMC": "Yes"
            },
            "DescriptionModule": {
                "BriefSummary": "RATIONALE: Measuring the amount of prostaglandin metabolite in urine samples and studying tissue samples in the laboratory from patients with ovarian cancer may help doctors identify and learn more about biomarkers related to ovarian cancer and may help the study of cancer in the future.\n\nPURPOSE: This laboratory study is measuring the amount of prostaglandin metabolite in urine samples from patients with ovarian cancer.",
                "DetailedDescription": "OBJECTIVES:\n\nDetermine the level of prostaglandin E_2 metabolite (PGE-M) in 24-hour urine samples collected prior to surgery or chemotherapy from patients with ovarian cancer.\nDetermine cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) expression by western blot and immunohistochemistry (IHC) in ovarian tumor tissue samples and matched normal ovarian tissue samples, if available, from these patients.\nCorrelate urine PGE-M levels with corresponding tissue COX-1 and COX-2 levels in urine and tissue samples from these patients.\n\nOUTLINE: This is a pilot study.\n\nPatients submit 24-hour urine specimens prior to surgery for evaluation of urinary levels of prostaglandin E_2 metabolite (PGE-M).\n\nPatients also undergo assessment of tissue obtained at the time of surgery, including ovarian tumor tissue, normal surface ovarian epithelium tissue (if available), and fixed tissue embedded in a paraffin block. Tissue samples are analyzed by western blot and IHC for cyclooxygenase-1 and cyclooxygenase-2 expression."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Ovarian Cancer"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "recurrent ovarian epithelial cancer",
                        "stage I ovarian epithelial cancer",
                        "stage II ovarian epithelial cancer",
                        "stage III ovarian epithelial cancer",
                        "stage IV ovarian epithelial cancer"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Observational",
                "PatientRegistry": "No",
                "DesignInfo": {
                    "DesignObservationalModelList": {
                        "DesignObservationalModel": [
                            "Case-Only"
                        ]
                    },
                    "DesignTimePerspectiveList": {
                        "DesignTimePerspective": [
                            "Prospective"
                        ]
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "7",
                    "EnrollmentType": "Actual"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "Known or suspected ovarian cancer",
                            "ArmGroupDescription": "Women who have a diagnosis of ovarian cancer or who are suspected of having ovarian cancer",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Genetic: protein expression analysis",
                                    "Other: immunohistochemistry"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Genetic",
                            "InterventionName": "protein expression analysis",
                            "InterventionDescription": "protein expression analysis",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Known or suspected ovarian cancer"
                                ]
                            },
                            "InterventionOtherNameList": {
                                "InterventionOtherName": [
                                    "protein expression analysis for PGE-M"
                                ]
                            }
                        },
                        {
                            "InterventionType": "Other",
                            "InterventionName": "immunohistochemistry",
                            "InterventionDescription": "immunohistochemical staining of tumor tissue to measure COX-1 and COX-2 levels",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Known or suspected ovarian cancer"
                                ]
                            },
                            "InterventionOtherNameList": {
                                "InterventionOtherName": [
                                    "immunohistochemistry staining methods"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Prostaglandin E2 metabolite (PGE-M) levels in 24-hour urine samples",
                            "PrimaryOutcomeDescription": "Patients will be collect their urine for 24 hours before they undergo any surgery or chemotherapy. Researchers will measure the amount of PGE-M in the urine.",
                            "PrimaryOutcomeTimeFrame": "Pre-surgical or chemotherapeutic treatment, over a 24-hour duration"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "COX-1 and COX-2 expression in ovarian tumor tissue and non-malignant tissue",
                            "SecondaryOutcomeDescription": "COX-1 and COX-2 expression will be measured in samples of patients' malignant ovarian samples and matched non-malignant samples (the latter if available).",
                            "SecondaryOutcomeTimeFrame": "Day of surgery"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Correlation of urine PGE-M levels with tissue COX-1 and COX-2 levels",
                            "SecondaryOutcomeDescription": "Patients' levels of urine PGE-M will be compared and contrasted with their levels of COX-1 and COX-2 in ovarian tumor tissue",
                            "SecondaryOutcomeTimeFrame": "After patients' surgery"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nDiagnosis of known or suspected ovarian cancer\nAge greater than 17 years\n\nExclusion Criteria:\n\nPregnant or nursing\nTaking steroids or non-steroidal anti-inflammatory drugs (NSAIDs) on a regular basis.\n\nPRIOR CONCURRENT THERAPY:\n\nNo concurrent chronic use of steroids or NSAIDs",
                "HealthyVolunteers": "No",
                "Gender": "Female",
                "MinimumAge": "17 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Child",
                        "Adult",
                        "Older Adult"
                    ]
                },
                "StudyPopulation": "Women with known or suspected ovarian cancer who are greater than 17 years in age.",
                "SamplingMethod": "Probability Sample"
            },
            "ContactsLocationsModule": {
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Marta Crispens, MD",
                            "OverallOfficialAffiliation": "Vanderbilt-Ingram Cancer Center",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000010051",
                            "ConditionMeshTerm": "Ovarian Neoplasms"
                        },
                        {
                            "ConditionMeshId": "D000077216",
                            "ConditionMeshTerm": "Carcinoma, Ovarian Epithelial"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000004701",
                            "ConditionAncestorTerm": "Endocrine Gland Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000010049",
                            "ConditionAncestorTerm": "Ovarian Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000000291",
                            "ConditionAncestorTerm": "Adnexal Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000005831",
                            "ConditionAncestorTerm": "Genital Diseases, Female"
                        },
                        {
                            "ConditionAncestorId": "D000052776",
                            "ConditionAncestorTerm": "Female Urogenital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000005261",
                            "ConditionAncestorTerm": "Female Urogenital Diseases and Pregnancy Complications"
                        },
                        {
                            "ConditionAncestorId": "D000091642",
                            "ConditionAncestorTerm": "Urogenital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000005833",
                            "ConditionAncestorTerm": "Genital Neoplasms, Female"
                        },
                        {
                            "ConditionAncestorId": "D000014565",
                            "ConditionAncestorTerm": "Urogenital Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000091662",
                            "ConditionAncestorTerm": "Genital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000004700",
                            "ConditionAncestorTerm": "Endocrine System Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000006058",
                            "ConditionAncestorTerm": "Gonadal Disorders"
                        },
                        {
                            "ConditionAncestorId": "D000002277",
                            "ConditionAncestorTerm": "Carcinoma"
                        },
                        {
                            "ConditionAncestorId": "D000009375",
                            "ConditionAncestorTerm": "Neoplasms, Glandular and Epithelial"
                        },
                        {
                            "ConditionAncestorId": "D000009370",
                            "ConditionAncestorTerm": "Neoplasms by Histologic Type"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M12664",
                            "ConditionBrowseLeafName": "Ovarian Neoplasms",
                            "ConditionBrowseLeafAsFound": "Ovarian Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M1704",
                            "ConditionBrowseLeafName": "Carcinoma, Ovarian Epithelial",
                            "ConditionBrowseLeafAsFound": "Ovarian Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M14540",
                            "ConditionBrowseLeafName": "Recurrence",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M5224",
                            "ConditionBrowseLeafName": "Carcinoma",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M7553",
                            "ConditionBrowseLeafName": "Endocrine Gland Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M12662",
                            "ConditionBrowseLeafName": "Ovarian Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M3333",
                            "ConditionBrowseLeafName": "Adnexal Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8633",
                            "ConditionBrowseLeafName": "Genital Diseases, Female",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M2877",
                            "ConditionBrowseLeafName": "Genital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M2876",
                            "ConditionBrowseLeafName": "Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M26783",
                            "ConditionBrowseLeafName": "Female Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M13817",
                            "ConditionBrowseLeafName": "Pregnancy Complications",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8089",
                            "ConditionBrowseLeafName": "Female Urogenital Diseases and Pregnancy Complications",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8635",
                            "ConditionBrowseLeafName": "Genital Neoplasms, Female",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M17005",
                            "ConditionBrowseLeafName": "Urogenital Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M7552",
                            "ConditionBrowseLeafName": "Endocrine System Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8853",
                            "ConditionBrowseLeafName": "Gonadal Disorders",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M12010",
                            "ConditionBrowseLeafName": "Neoplasms, Glandular and Epithelial",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M12005",
                            "ConditionBrowseLeafName": "Neoplasms by Histologic Type",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "T4352",
                            "ConditionBrowseLeafName": "Ovarian Cancer",
                            "ConditionBrowseLeafAsFound": "Ovarian Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "T4354",
                            "ConditionBrowseLeafName": "Ovarian Epithelial Cancer",
                            "ConditionBrowseLeafAsFound": "Ovarian Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BXS",
                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC19",
                            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC23",
                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "Rare",
                            "ConditionBrowseBranchName": "Rare Diseases"
                        }
                    ]
                }
            }
        }
    }
}